← Open Payments lookup

JULIE ZULKOSKY: Open Payments

NPI 1184214801 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,450 in 173 payments from 17 companies in 2025. Trend: 2023 $2,116 · 2024 $1,552 · 2025 $2,450

Food & beverage: $2,450
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$450
Otsuka America Pharmaceutical, Inc.26$322
Vanda Pharmaceuticals Inc.20$317
ABBVIE INC.29$305
Axsome Therapeutics, Inc.22$302
Lundbeck LLC9$171
Alkermes, Inc.15$146
E.R. Squibb & Sons, L.L.C.6$101
Noven Therapeutics, LLC4$67
Janssen Pharmaceuticals, Inc3$59

Products named: CAPLYTA, REXULTI, Auvelity, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, ARISTADA, COBENFY.

Industry payments across NE — which companies pay providers there.